CONGENITAL HYPERINSULINISM
Clinical trials for CONGENITAL HYPERINSULINISM explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL HYPERINSULINISM trials appear
Sign up with your email to follow new studies for CONGENITAL HYPERINSULINISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare sugar disorder: experimental drug aims to slash dangerous lows
Disease control OngoingThis study tests an investigational drug called RZ358 in 56 people aged 3 months to 45 years with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. Participants receive RZ358 or a placebo added to their usual treatments for 24 weeks, followed by an…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
New weekly shot aims to tame rare low-blood-sugar disease in kids and adults
Disease control OngoingThis study tests a new drug called HM15136 in people aged 2 and older with congenital hyperinsulinism, a rare condition that causes dangerously low blood sugar. The drug is given as a weekly shot for 8 weeks, on top of their usual treatments. The goal is to see if it is safe and …
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE2 • Sponsor: Hanmi Pharmaceutical Company Limited • Aim: Disease control
Last updated May 17, 2026 04:11 UTC
-
New hope for kids with rare low blood sugar disorder: dasiglucagon shows promise in Long-Term trial
Disease control OngoingThis study tests the long-term safety of a drug called dasiglucagon in children with congenital hyperinsulinism, a rare condition causing dangerously low blood sugar. About 42 children who completed earlier trials will receive dasiglucagon as a continuous shot under the skin. The…
Matched conditions: CONGENITAL HYPERINSULINISM
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated May 11, 2026 20:47 UTC